April 21st 2025
Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Evaluating Treatment Goals, Preferences in Parents and Young Patients With Psoriasis
October 15th 2021Pediatric populations, young adults, and parents all identified differing goals and preferences of treatment for psoriasis, with the most important treatment goals overall cited as lesion prevention and reduction.
Read More
Study Finds Significant Price Transparency Concerns for Ophthalmologic Procedures
October 11th 2021An evaluation of price transparency tools for ophthalmologic procedures found significant usability, availability, and variability issues, which may disproportionately impact vulnerable populations.
Read More
Environmental Protection Agency (EPA) to announce plan on strengthening regulations against certain chemicals; risk of emergency complications increased in pregnant women with symptomatic COVID-19; fully vaccinated, heavy marijuana users with substance abuse disorder linked with higher susceptibility to breakthrough infection.
Read More
Observation After Adenotonsillectomy Recommended for Patients With Extreme Pediatric OSA
October 8th 2021Pediatric patients with extreme obstructive sleep apnea (OSA) may have a higher risk of needing respiratory support after undergoing corrective adenotonsillectomy, warranting the need for postoperative observation in these populations.
Read More
Dr Robert Groves Explains Psychographics and How the Data Are Used
October 8th 2021Psychographics is a way of categorizing someone based on their everyday behaviors using data that are collected every time they go to the store or post on social media, said Robert Groves, MD, executive vice president and chief medical officer at Banner | Aetna. In health care, psychographics can be used to positively influence someone to their benefit.
Watch
Providing Patients With Cancer Access to Affordable Housing During Treatment
October 7th 2021Patients traveling for cancer treatment often incur financial burdens. The members of the Alliance of Dedicated Cancer Centers should play a role in mitigating housing-associated costs for patients during cancer treatment.
Read More
Brodalumab May Enhance Skin Clearance, QOL vs Ustekinumab for Psoriasis
October 6th 2021Patients with moderate to severe psoriasis were shown to achieve and maintain higher levels of complete skin clearance and quality of life when treated with brodalumab vs ustekinumab, regardless of the presence of lifestyle risk factors.
Read More
Ruxolitinib Has Cost-effectiveness, Survival Benefits for Myelofibrosis vs Competitors
October 6th 2021Research presented at EHA2021 shows that the JAK 1/2 inhibitor ruxolitinib produced cost-effective benefits per quality-adjusted life-year and increased the overall survival rate for patients with myelofibrosis.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
Study Finds Significant Link Between Obstructive Sleep Apnea, White Matter Hyperintensities
October 5th 2021Patients with obstuctive sleep apnea were found to be significantly more likely to have brain white matter hyperintensities, lesions known to signal brain aging and potential risk of Alzheimer disease.
Read More
Francis Collins, MD, PhD, will step down as director of the National Institutes of Health (NIH) at the end of the year; the Biden administration ends a ban on federal funds for clinics that provide abortion referrals; the Pfizer/BioNTech COVID-19 vaccine is 90% effective in preventing hospitalization and death 6 months after the second dose.
Read More
High Rate of Secukinumab Retention Shown Long Term in Patients With Psoriasis
October 1st 2021Secukinumab was associated with a high rate of short- and long-term drug survival in the treatment of patients with psoriasis, with factors such as obesity and prior biologic use linked to discontinuation of use.
Read More